Back

Impact of age on health status after TAVI or SAVR in low risk patients with severe aortic stenosis: results from the PARTNER 3 Trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: TAVI in different ages and sizes Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Michael Brener

Columbia University Medical Centre, New York (United States of America)

4 More presentations in this session

Presentation thumbnail
Temporal trends of aortic valve replacement modalities by age group in the united states 2015 - 2023
Doctor M. Barghout (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Transcatheter versus surgical aortic valve replacement in patients younger than 65 years: analysis from the national inpatient sample database
Doctor M. Ismayl (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes after transcatheter aortic valve implantation: derivation and validation of the long-TAVI prediction model
Doctor F. Wenzl (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Transcatheter aortic valve replacement with balloon-expandable and self-expandable valves in Japanese patients with large annulus: the OCEAN-TAVI registry
Doctor K. Onishi (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI in different ages and sizes
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Correlations with anatomic specimens
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Presentation
Percutaneous devices for valve repair and replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources